Podcasts about Specialty pharmacy

In this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, speaks with Matthew G. Bowles, PharmD, MBA, CSP, Pharmacy Clinical Team Lead with Vanderbilt Specialty Pharmacy, Vanderbilt Health, and lead author on the study “Getting to specialty treatment in dermatologic inflammatory conditions: Treatment requirements and patient journey,” published February 2025 in the Journal of Managed Care & Specialty Pharmacy. They discuss the reasons for conducting and results of the study, as well as the impacts the study may have on specialty and managed care pharmacy.

In this episode, Eric Huckins discusses trends shaping specialty pharmacy, from managing high-cost infusions and direct-to-consumer models to preparing for the Inflation Reduction Act. He shares how Lumicera is partnering with health systems to enhance efficiency, integration, and patient care.This episode is sponsored by Lumicera Health Services.

In this episode of Disruption/Interruption, host KJ interviews Mark Mincy, Chief Commercial Officer at US RX Care, about the hidden complexities and conflicts of interest in the pharmacy benefits industry. Mark shares how his company is disrupting the status quo by demanding transparency, eliminating conflicts, and helping employers reclaim millions in savings. The conversation uncovers the tangled web of PBMs, rebates, and the urgent need for legislative and technological change. Key Takeaways: The PBM System is Riddled with Conflicts of Interest [2:34]Mark explains how pharmacy benefit managers (PBMs) and consultants often act in their own financial interest, not the employer’s or patient’s, leading to inflated drug costs. Rebates and Purchasing Contributions Inflate Drug Prices [8:59]The system of rebates and retrospective payments to PBMs can account for up to 80% of a drug’s cost, forcing manufacturers to raise prices and employers to pay more. Transparency and Fiduciary Duty are Essential for Reform [21:37]Mark’s company, US RX Care, operates with complete transparency, passes back all rebates, and offers per-member-per-month guarantees to eliminate guesswork and conflicts. Employers and Consumers Can Take Action [33:34]Mark recommends joining healthcare purchaser coalitions, hiring ERISA attorneys, and demanding non-conflicted consultants to protect interests and drive industry change. Quote of the Show [31:27]:"Everything's intertwined. You want to move and do the right thing. These employers are between a rock and a hard place, so I do think some legislative action needs to occur." – Mark Mincy Join our Anti-PR newsletter where we’re keeping a watchful and clever eye on PR trends, PR fails, and interesting news in tech so you don't have to. You're welcome. Want PR that actually matters? Get 30 minutes of expert advice in a fast-paced, zero-nonsense session from Karla Jo Helms, a veteran Crisis PR and Anti-PR Strategist who knows how to tell your story in the best possible light and get the exposure you need to disrupt your industry. Click here to book your call: https://info.jotopr.com/free-anti-pr-eval Ways to connect with Mark Mincy: LinkedIn: http://www.linkedin.com/in/mark-mincy-a185497 Company Website: https://us-rxcare.com How to get more Disruption/Interruption: Amazon Music - https://music.amazon.com/podcasts/eccda84d-4d5b-4c52-ba54-7fd8af3cbe87/disruption-interruption Apple Podcast - https://podcasts.apple.com/us/podcast/disruption-interruption/id1581985755 Spotify - https://open.spotify.com/show/6yGSwcSp8J354awJkCmJlDSee omnystudio.com/listener for privacy information.

340B Insight wants to make our podcast the best it can be. To help us succeed, we'd like to hear your thoughts. Please take just a few minutes to complete our listener survey, and we will enter you in a drawing to win a $100 gift card! To participate, please go to 340bpodcast.org/survey.The large and growing field of specialty pharmacy means new opportunities and challenges for ensuring patients receive the specialty drugs they need and stay on the therapies that might save their lives. St. Luke's Health System, based in Boise, Idaho, has approached this mission by embedding clinical pharmacists in the specialty pharmacy space and using 340B as a critical tool. We speak with Josh Weber, senior director of ambulatory retail and specialty pharmacy services at St. Luke's, to learn more.How Clinical Pharmacists Can Be a “Value Multiplier”Embedding clinical pharmacists in their specialty pharmacies improves operations in myriad ways. These pharmacists can take the burden off other providers by meeting with patients to go over their drug regimens, coordinating care, and running split-fill programs to reduce waste. At St. Luke's, the approach has improved patient adherence to medications and reduced the time between the specialty prescription and the patient having the medication in hand to less than 48 hours – far quicker than the industry standard.340B Savings Are Key to the InvestmentWeber says cost savings from 340B are critical in calculating how they embed resources into specialty pharmacy, noting that improving adherence and retention can increase 340B savings exponentially. These savings then can enable health systems such as St. Luke's to reinvest in their internal specialty pharmacies, provide more patient cost assistance and unreimbursed care, and ultimately shield themselves from headwinds such as drugmaker contract pharmacy restrictions.Embedding Pharmacists Depends on Hospital-Specific FactorsFor hospitals considering following the lead of St. Luke's Health System, Weber said a variety of factors such as patient volume, payer mix, and drug spend can call for a variety of service models and investment strategies. Harnessing data such as heat maps showing where patients are and which clinics they visit can inform how best to embed pharmacists and ultimately improve specialty pharmacy care for patients.Resources:Drugmakers Release 340B Rebate Pilot Program DescriptionsHRSA 340B Rebate Model Pilot ProgramBeacon Rebate Model Resources

During this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, speaks with Sheri Wallace, Account Representative at AcariaHealth Specialty Pharmacy, and Diane Omdahl, RN, MS, founder of 65 Incorporated, published author and consultant on Medicare, to unpack the complexities of the Medicare Prescription Payment Plan (MPPP). Drawing on decades of patient access experience and the finer points of Medicare, they share insights on how these changes impact patients, providers, and pharmacies alike. Learn the importance of education, transparency, and advocacy in ensuring patients don't fall through the cracks during these changes. Whether you're a provider, pharma partner, or patient advocate, this episode offers practical guidance and expert perspectives to help you navigate the evolving Medicare landscape.

This episode's Community Champion Sponsor is Ossur. To learn more about their ‘Responsible for Tomorrow' Sustainability Campaign, and how you can get involved: CLICK HEREEpisode Overview: Growing a company from $46,000 to $30 million in six years doesn't happen by accident—it requires vision, grit, and the right team. Our next guest, Beth Lachance, is the CEO and founder of Global Medical Virtual Assistants, where she's revolutionizing administrative support for medical practices nationwide. With 16 years as an entrepreneur and over 22 years of healthcare leadership experience, she brings strategic vision and hands-on execution to building high-performing distributed teams. Driven by a passion for operational excellence and leveraging global talent, Beth shares how GMVA is transforming healthcare staffing through HIPAA-compliant virtual assistants from the Philippines. Join us to discover how her team is helping practices reclaim time, reduce costs, and refocus on patient care. Let's go!Episode Highlights:The Right Team Matters - Finding the right advisors and team members is critical, even when it means parting ways with early supporters.Leadership Evolves with Growth - Different business stages require different leaders; Beth is now bringing on a CFO as GMVA scales.$46K to $30M in Six Years - GMVA's explosive revenue growth demonstrates massive demand for virtual healthcare staffing.Reimagining Healthcare Work - GMVA transforms medical practices through remote administrative support, freeing providers to focus on patients.Tough Decisions Drive Success - Beth learned that moving on from trusted early team members, though painful, unlocks company potential.About our Guest: Beth Lachance is the CEO and founder of Global Medical Virtual Assistants (GMVA), whereshe drives sustainable growth and operational excellence for a company revolutionizingadministrative support for U.S. medical practices. With 16 years as an entrepreneurspecializing in real estate and over 22 years of corporate leadership in Surgical Device,Pharmaceutical, and Specialty Pharmacy industries, Beth blends strategic vision with hands-on execution to build high-performing teams and achieve long-term success.A former Division I gymnast on full scholarship at the University of Florida, Beth earned herBachelor of Science in Health Sciences, a testament to her discipline and goal-drivenleadership.Links Supporting This Episode: Global Medical Virtual Assistants Website: CLICK HEREBeth Lachance LinkedIn page: CLICK HEREGlobal Medical Virtual Assistants LinkedIn: CLICK HEREMike Biselli LinkedIn page: CLICK HEREMike Biselli Twitter page: CLICK HEREVisit our website: CLICK HERESubscribe to newsletter: CLICK HEREGuest nomination form:

In this episode, current and past executive committee members for the Section of Specialty Pharmacy Practitioners sit down together to share stories and discuss the impact made by the 2024 Distinguished Service Awardee, Tara Kelley.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

The Pharmacy Podcast Network is back on the show floor at the NASP Annual Expo, live in Denver, CO! Thank you JB Consulting for Sponsoring this episode! On part one of this series we interview: Jennifer Noonan with Accessia Health Shaun Jensen with JB Consulting Kevin Kallmes with Nested Knowledge AI Lee Pratt with ProChant Mai Tang with Two Trees Consulting Nick Calla with Orsini Reed Kalna with Kaiser Permanente Richard Brook with Better Worldwide Health Ryan Clarke with Keysource Sheila Arquette, President and CEO of the NASP

The Pharmacy Podcast Network is back on the show floor at the NASP Annual Expo, live in Denver, CO! Thank you Accessia for Sponsoring this episode! On part two of this series we interview: Jennifer Noonan with Accessia Health Nick Negri with ALTOR Cecila Byers with Surescripts Jill Paslier with Specia Jon Hamrick with Curatio Advisors Jonathan Orgurchak and Brandon Hardin Steve Pharmacy Attorney Tammy Dean with Cold Chain Technologies

The Pharmacy Podcast Network is back on the show floor at the NASP Annual Expo, live in Denver, CO! Thank you JB Consulting for Sponsoring this episode! On part one of this series we interview: Christine Tang Wilson with Lumicera Health Services Amanda Awe with VLP Christopher Corsi, CEO, CassianRx Hayley Burgess with Inovalon Eric Robertson with DoseSpot Harry Travis with The Travis Group LLC Ethan Wynn with Sphinx Strategies Heidi Polleck with Outcomes    

In this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, sits down with Trey Holterman, CEO and Co-Founder of Tennr, a healthcare referral automation platform. They explore Tennr's journey from startup to industry leader and how focused technology speeds patient access, with a look towards what the future holds for patient engagement and care personalization.

This episode discusses the remainder of the results of the work from home survey conducted in 2024 by members of the Section of Specialty Pharmacy Practitioners Advisory Group on Operational and Workforce Development. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode of the NASP Podcast, Sheila Arquette, President & CEO of the National Association of Specialty Pharmacy, sits down with Hillary Gretton, Director of Data Strategy at Claritas Rx. Together, they explore today's challenges in market access and patient journey analytics, and how Access Analytics is helping specialty pharmacies, payers, and partners tackle these barriers. The conversation highlights real-world use cases from Claritas Rx's recent whitepaper, From Prescription to Abandonment: How 31% of Specialty Medications Go Unfilled Across Therapeutic Areas, showing how better data can drive better outcomes.

This special episode of the NASP podcast features MedAdvisor leaders Megan Butterfield, Vice President of Network Solutions and Vinod Subramanian, Chief Operating and AI Officer in conversation with Shelia Arquette, President & CEO of NASP, as part of a collaborative spotlight for MedAdvisor Solutions' Beyond the Script podcast series. They discuss how AI, when applied thoughtfully, can help us not only meet the demands of patients' increasingly intricate care journeys, but do so in a way that enhances the human experience, facilitating personalized engagement, real-time education, empathy and trust, while keeping what's special about specialty pharmacy. 

In recent years, pharmacy school enrollment and pursuit of pharmacy residency has declined nationally. This trend has impacted specialty pharmacy residencies in particular because pharmacy students tend to have less familiarity with specialty pharmacy as a practice setting. This podcast will target specific strategies to recruit highly successful candidates for careers in specialty pharmacy. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, speaks with Jonathan L. Swichar, Partner and Chair of the Duane Morris Pharmacy Litigation Group, and Bradley A. Wasser, Partner, Duane Morris, LLP. They discuss the dramatically shifting legal and regulatory landscape facing non-PBM affiliated specialty pharmacies and recent federal efforts that are reshaping the ways specialty pharmacies do business.

This episode dives into the Medicare Prescription Payment Plan (M3P), launched in 2025, and its impact on specialty pharmacies across the U.S. The episode discusses how this policy is changing patient access, pharmacy reimbursement, and operational strategies, while also highlighting the challenges and opportunities specialty pharmacies face in adapting to these shifts. Whether you're a healthcare professional, pharmacist, or policy expert, this episode unpacks everything you need to know about M3P and its role in shaping the future of specialty pharmacy. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This episode discusses a portion of the results of the work from home survey conducted in 2024 by members of the Section of Specialty Pharmacy Practitioners Advisory Group on Operational and Workforce Development.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode, Becker's Healthcare speaks with Jim Blondin, Senior Director of Digital Product Strategy at Accredo Specialty Pharmacy, about the strategic benefits of integrating specialty pharmacy into EHR workflows. The discussion explores how this integration can reduce workflow friction, improve care coordination, and enhance both patient and provider experiences. Tune in for insights relevant to pharmacy leaders, CIOs, and healthcare executives navigating digital transformation.This episode is sponsored by Accredo Specialty Pharmacy.

During this podcast we will explore strategies and provide real-world examples to help preceptors increase engagement from students during their specialty pharmacy learning experiences. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In 2024, ASHP conducted the fourth nationwide survey on specialty pharmacy. In this episode, members of the author team and advisory panel join us to share key takeaways and lessons learned from this most recent survey.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode of the NASP Podcast, Sheila Arquette, President & CEO  of NASP, speaks with Dr Andrew Lindsley, US Medical Director at  Amgen and Dr Ash Davé, Director, Medical Value and Population  Health at Amgen, to discuss TEZSPIRE® (tezepelumab-ekko). 

In this episode, Ameet Wattamwar, Director of Health Systems Strategy at Shields Health Solutions, discusses the role of specialty pharmacy & improving patient outcomes.

In this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, speaks with Jeffrey S. Baird, Esq., Chairman of the Health Care Group at Brown & Fortunato, P.C. and Bradley W. Howard, shareholder and director at Brown & Fortunato, P.C. In today's environment, it is challenging enough to profitably run a specialty pharmacy. The pharmacy needs to avoid the additional challenge of inquiries, audits and investigations by governmental agencies and PBMs. This podcast will discuss the proactive steps the specialty pharmacy can take to lower the risk of inquiries, audits and investigations. This podcast will also set out steps the pharmacy can take to resolve inquiries, audits and investigations before they spin out of control. The podcast will focus on the following: • Corporate Compliance Program – The specialty pharmacy needs to implement a robust compliance program that is specific to the pharmacy's business model. Such a program will head off many problems before they arise…and a compliance program will resolve problems, once arisen, before they spin out of control. • PBMs – A PBM is in a stronger negotiating position than that of the specialty pharmacy. At the end of the day, the PBM “possesses the pharmacy's money.” This podcast will discuss the steps the pharmacy should take to establish a “win-win” relationship with a PBM. Doing so will eliminate uncertainty and prevent many problems from arising. However, if the PBM ends up bringing an inquiry, audit or investigation against the pharmacy, the podcast will set out the steps the pharmacy should take to resolve the inquiry, audit or investigation without it devolving into an adversarial action. • Governmental Agencies – There are a number of federal and state governmental agencies that a specialty pharmacy may have to deal with. These include (i) the Department of Justice, (ii) the Office of Inspector General, (iii) the DEA, (iv) the FDA, (v) state Attorneys General, and (vi) State Boards of Pharmacy. This podcast will discuss the steps the pharmacy should take when it is investigated by a governmental agency. As with working with PBMs, the pharmacy should strive to resolve a government investigation before it spins out of control. 

A few years ago we had the pleasure of speaking with Jonathan Ogurchak about the success of his company STACK. Now we have invited him back to see how the business has progressed and learn about his new venture, Zeal Specialty Pharmacy.   As a pharmacist, Jonathan observed significant inefficiencies and a need to modernize processes. This set him on a course to develop and deliver better technology that would ultimately improve patient care. Today, he is a recognized serial entrepreneur, a leader in technology, and a man whose latest endeavor is centered on the delivery of medication to individuals with rare diseases.   Here are highlights of our conversation:   -An Update on STACK: The business has expanded its product offerings including a new product called On Queue, an operations workflow platform to enhance the pharmacy patient journey and capture valuable data. They now have customers in the US, Canada, Mexico, and Dubai.   -Healthcare Compliance: STACK software helps organizations manage compliance by providing easy access to regulations for different states and purposes and automating processes for accreditation, compliance, and training for pharmacies.   -Zeal's Branding Strategy: Jonathan explained the origin of the company name "Zeal" as a play on the term "zebra" in the medical community, representing rare and orphan diseases. The zebra also represents an effort to connect with patient communities through tasteful and purposeful branding.   -Advice for Founders: Finding a mentor and maintaining a network for personal and professional growth is critical for new founders. He shared his experiences as a business owner and entrepreneur, highlighting the need to foster a healthy balance between work and personal life. He shared the significance of family and prioritizing time with loved ones, as businesses and jobs can change but family remains constant.   -Building Culture:  Jonathan discussed the pharmacy's leadership development initiative, which includes a book club focused on customer service and growth. He mentioned the book "Unreasonable Hospitality" and the Disney Institute program. Jonathan also shared that he encourages team members to explore different industries for innovative ideas.         About the guest: Jonathan Ogurchak, PharmD, CSP, CPHIMS, is a specialty pharmacy veteran, having served in numerous roles across pharmacies, associations, and education for the last 15 years.   Currently, he is the CEO & Founder of STACK, a software firm with two commercially available platforms: its namesake, STACK, a pharmacy information management platform designed to curate and organize information necessary to run successful pharmacies, professional associations, and higher education institutions; and OnQueue, a workflow platform built to optimize the patient journey for pharmacies and clinics. He is also the CEO and co-founder of Zeal Specialty Pharmacy, an independent rare-disease pharmacy leveraging both the above technologies to create the best experiences possible for patients, prescribers, and pharma partners across the country.   Jonathan is an adjunct faculty through Duquesne University and the University of Pittsburgh, precepts pharmacy students virtually at 25 schools of pharmacy nationwide, focused on specialty pharmacy programs and processes, and his specialty pharmacy textbook is in pre-publication.   Connect with Jonathan: Website: https://www.managewithstack.com/ Website: https://www.zealsp.com/   Connect with Allison: Feedspot has named Disruptive CEO Nation as one of the Top 25 CEO Podcasts on the web, and it is ranked the number 6 CEO podcast to listen to in 2025! https://podcasts.feedspot.com/ceo_podcasts/ LinkedIn: https://www.linkedin.com/in/allisonsummerschicago/ Website: https://www.disruptiveceonation.com/    #CEO #leadership #startup #founder #business #businesspodcast  Learn more about your ad choices. Visit megaphone.fm/adchoices

In this powerful episode of This Week in Pharmacy, Todd Eury explores the growing national backlash against pharmacy benefit managers (PBMs)—starting with bold action in Arkansas. Following Gov. Sarah Huckabee Sanders' recent signing of legislation to limit PBM influence, Arkansas has become a flashpoint in the nationwide struggle to protect independent pharmacies and ensure fair drug pricing. Special guest from Arkansas, Doctor's Orders Pharmacy Owner, Lelan Stice, as we dig into what this legislation means, how states like Alabama are following suit, and why pharmacists across the U.S. are calling for transparency, accountability, and reform. PBMs are under increased legal and political scrutiny across multiple states Independent pharmacies are gaining new allies in their fight for survival Legislative momentum is growing—this could be a tipping point Patients, too, are paying the price for PBM overreach Pharmacists must stay informed and involved in local/state policy Full AP article: APNews.com – Arkansas Takes on PBMs TWIRx Feature: Lumicera Health Services Guest: Dr. Ben Heiser, PharmD – General Manager, Specialty Pharmacy, Lumicera Health Services In this special TWIRx segment, This Week in Pharmacy dives into the world of specialty pharmacy with Dr. Ben Heiser of Lumicera Health Services, a nationally recognized leader in delivering specialty drug solutions with a patient-first approach. Dr. Heiser discusses how Lumicera leverages data-driven care models, collaborative payer partnerships, and a commitment to access and affordability to redefine what it means to support patients with complex, chronic conditions. From pharmacy innovation to value-based outcomes, this interview offers a behind-the-scenes look at one of the most forward-thinking organizations in specialty care. Lumicera Health is the Pharmacy Podcast Network sponsor for the AXS25 Press Coverage, learn more about  Lumicera here:  https://www.lumicera.com/  Subscribe to all 40+ Pharmacy Podcast Network podcasts from one link:  https://linktr.ee/pharmacypodcast 

Specialty medication spending is projected to rise sharply through 2026, intensifying pressure on health systems to control costs while improving patient outcomes. In this episode of Healthcare Insider, Cardinal Health's Mike Brown, vice president of managed services, and Naveen Mansukhani, director of specialty and ambulatory pharmacy solutions, break down the critical role specialty pharmacies play in managing spend, capturing revenue and retaining patients within the care continuum. They share real-world examples of how hospitals large and small are benefiting from tailored pharmacy models and discuss how to overcome common challenges such as labor shortages, compliance and ongoing accreditation requirements. Listen to learn how your organization can build a scalable, compliant specialty pharmacy strategy that supports value-based care and long-term success.

In this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, speaks with Jessie Heaton, PharmD, MBA, CSP, Vice President of Specialty and Infusion at Maxor, and Michelle Mulgrew, PharmD, Vice President of Commercial Specialty Market Development at Maxor, about specialty pharmacy's role in rare disease patient care management and how to empower patients, prescribers, and manufacturers to navigate complex clinical needs.  

In this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, speaks with Dean Erhardt, President & CEO of D2 Solutions. They discuss how specialty pharmacies can leverage technology and data analytics to navigate complex accreditation demands and automate high volume low value activity workflows so the expert clinicians can do what they do best - care for patients.

In this podcast, Dr. Chelsea Renfro and Dr. Autumn Zuckerman discuss the AJHP Special Feature, “Ultra-complex specialty medications: Meeting the challenges of significant medication requirements through an integrated specialty pharmacy model,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

The "Pharmacy 50" Awards, recognizing the 50 Most Influential Leaders in Pharmacy, have officially been announced for 2024! This prestigious honor celebrates the most inspiring, innovative, and impactful figures in pharmacy who are driving advancements in patient care, business development, and industry reform. Now in its fourth year, the Pharmacy 50 saw a record-breaking 30% increase in peer recognition, demonstrating the growing influence of pharmacists across multiple sectors, including Community Pharmacy, Long-Term Care, Specialty Pharmacy, Health System, Digital Health, and more. Voting took place between November 15 and December 20, 2024, and this year's winners include some of the most distinguished names in the industry, with returning honorees and new leaders making their mark on pharmacy's evolving landscape.   Pharmacy 50 Class of 2024 (Listed by most votes) Anthony V. Minniti, BScPharm, RPh, FACA Jay Phipps, PharmD, MBA, FACA, FACVP Dr. Nhu Truong, PharmD Jeff Harrell, PharmD Naveena Gorrepati, PharmD Jeremy Counts, PharmD Darshan Kulkarni, PharmD, Esq. Shahida Choudhry, PharmD** (4-time winner) April Nguyen, PharmD, RAC, MPH Robin Barrett, PharmD Cody R. Morcom, PharmD, BCPS, LSSGBC Ethan Melillo, PharmD, CDOE Randy McDonough, PharmD, MS, BCGP, BCPS, FAPhA Chelsea Hustad, PharmD, CSP Greg Reybold, Esq. Renee Malarbi Rayburg, BPharm Walter Oronsaye, PharmD, MS Chidimma Gold Eneyo, PharmD Jessica Beal-Stahl, PharmD Tamar K. Lawful, PharmD, APh, CNGS DeLon Canterbury, PharmD, BCGP Frank Harvey, MBA Mike Johnston, CPhT-Adv Brent Edison, PharmD Aleata Postell Courtney B. Smith, PharmD, CSP, BCMTMS Jennifer Morrison, PharmD Katrina Azer, BPharm Josh Pirestani Bil Schmidtknecht Ultan McGlone, PharmD Katarina (Kati) Forbes, PharmD Christopher Bowens, PharmD Mahmoud Zegar, PharmD Alexandra (Ally) LaStella, PharmD Kunal Vyas Jenny Bingham, PharmD Shaun Jensen Fiona Sartoretto Verna Brandi Chane, PharmD Jonathan Ogurchak, PharmD, CSP, CPHIMS Jena Quinn, PharmD Jordan Smith, PharmD, AAHIVP, CPGx Chris Antypas, PharmD Lorneka Joseph, PharmD Derek Borkowski, PharmD Sue Ojageer, PharmD, CPGx Benjamin Jolley, PharmD Anisha Patel, BPharm Jeff Malone Pharmacy 50 Awards Ceremony - January 29, 2025 The official awards ceremony will be hosted at the Pharmacy Podcast Network headquarters in Brownsville, PA. The event will feature: A networking session at 2 PM ET The Pharmacy 50 LIVE Stream at 3 PM ET, where winners will be highlighted and interviewed Industry leaders, past winners, and special guests will be in attendance to celebrate the remarkable contributions of these pharmacy professionals. The Pharmacy 50 Awards were created to recognize individuals who are pushing the boundaries of pharmacy care. From technology and advocacy to clinical services and business innovation, this year's winners represent the best of the best across the pharmacy profession. "Each year, we see more pharmacists taking charge of their profession-leading change, innovating care models, and fighting for patient access. The Pharmacy 50 recognizes these change-makers and amplifies their voices," said Todd Eury, Founder of Pharmacy Podcast Network. This year's Pharmacy 50 Awards were proudly sponsored by RxInsider and Independent Pharmacy Cooperative (IPC), whose ongoing support of the pharmacy industry continues to fuel growth and advocacy. "RXinsider is thrilled to support the Pharmacy Podcast Network's Pharmacy50 Awards, celebrating the outstanding leaders and innovators shaping pharmacy. As a company committed to advancing pharmacy through education and innovation, RXinsider is honored to join this prestigious initiative that recognizes excellence and inspires progress." stated Gregory Cianfarani RPh, CEO of RxInsider. "We're excited to celebrate the achievements of our peers and contribute to highlighting the individuals and organizations making a meaningful impact in the pharmacy community." For more details about the Pharmacy 50 Awards, visit Pharmacy50.us About Pharmacy Podcast Network (PPN) Pharmacy Podcast Network is the leading media platform dedicated to pharmacy professionals, offering thought leadership, industry insights, and expert-driven content through podcasts, webinars, and live events. Since its founding in 2009, PPN has been the voice of pharmacy, covering community pharmacy, specialty pharmacy, digital health, advocacy, business development, and more.

In this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, speaks with Simone Colgan Dunlap, National Vice Chair of the Quarles' Health & Life Sciences Practice Group and Candace Lerman, JD, at Rare Candace. They discuss the current impacts of AI on the healthcare space and how those within specialty pharmacy may implement AI in ways that prevent detrimental outcomes, stay compliant with evolving regulations, avoid legal pitfalls, and ultimately benefit patients.

During this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, speaks with Ketan Mehta, the visionary CEO of PrimeRx. They explore how the advancement of technology has changed the landscape of specialty pharmacy and ways digital integration can help specialty pharmacies achieve a patient-centric holistic ecosystem.

Jonathan Ogurchak, PharmD, CEO of Zeal Specialty Pharmacy and STACK, shares his innovative journey of transforming specialty pharmacy through smarter technology. Learn how he's empowering pharmacists, improving patient outcomes, and disrupting the industry with his dual focus on pharmacy operations and groundbreaking tech solutions. A must-listen for pharmacy innovators!

In this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, speaks with Bridgette Kanz Schroader, PharmD, MPA, BCOP, Associate Director within the Medical Affairs Strategy & Publications team at Market Access & Healthcare Consulting, part of Cencora, and Laurie Fayzio, Head, Manufacturer Strategy, at FormularyDecisions. They explore the changing landscape of digital communication between biopharma companies and healthcare decision makers (HCDMs) and delve into 3 key topics that are crucial for effective engagement in the digital era with key decision makers: research on how HCDMs are utilizing digital resources and valuable insights into their preferences, how biopharma companies are adapting to meet the evolving needs of HCDMs in a post-pandemic peak era, and innovative strategies to optimize digital communications and the implications for stakeholder relationships.

Before founding inGENEious RX Incorporated, a boutique pharmacogenomics consulting firm, Dr. Winslow directed pharmacy business operations and clinical pharmacy programs in retail, hospital, long-term care, and public health pharmacies for Walmart Stores, Community Health Systems, Neil Medical Group, and the North Carolina Department of Health and Human Services. Since founding inGENEious RX over eleven years ago, Dr. Winslow has worked with numerous distinguished vendors in the pharmacogenomics industry including Translational Software, Admera Health, Genemarkers, National Association of Chain Drug Stores, Kentucky Teachers' Retirement System, GenXys, and Thermo Fisher Scientific.  A sought-after pharmacogenomics subject matter expert, Dr. Winslow, has authored PGx payer databases and billing and coding algorithms and served Mintz Law as the expert medical necessity reviewer of Medicare PGx claims. She is an authority in pharmacogenomics access and reimbursement and specializes in business strategy consulting for pharmacogenomics stakeholders.   Dr. Winslow is an Advanced Pharmacy Practice Experience preceptor for Manchester University School of Pharmacy PharmD/Masters in PGx students and a registered trainer for the University of Pittsburgh's Test2Learn (TM) Community PGx Certificate Program. Dr. Winslow is a member of the Clinical Pharmacogenetics Implementation Consortium, the NCPDP PGx Task Force, and the Get the Medications Right Institute.  In 2021, Welp Magazine recognized Dr. Winslow's podcast, the PGx for Pharmacists Podcast, as the world's ninth most listened-to genetics podcast. Her podcast shares the top 20 most listened-to genomics podcast list with genomics podcasts created by such notable podcasters as the National Cancer Institute and the American Heart Association. The Pharmacy Podcast Network recognized Dr. Winslow in 2021 as a Top 50 pharmacy influencer. Entities frequently recruit Dr. Winslow to present PGx topics. She has presented at conferences for the National Association of Boards of Pharmacy, the National Association of Specialty Pharmacy, the Inovalon Customer Congress, and the Association for Molecular Pathology and on the Labroots' and Precision Medicine Institute's platforms.  Dr. Winslow earned her Bachelor of Science in Biology and Doctor of Clinical Pharmacy degrees from Campbell University. Lexi Wensel is a 2024 Manchester University School of Pharmacy graduate where she earned her Doctorate in Pharmacy and Masters in Pharmacogenomics. When this episode was recorded in April 2024, Lexi was completing an advanced pharmacy practice experience with Dr. Becky Winslow, preceptor for Manchester University School of Pharmacy. While studying to become a pharmacist, Lexi gained practical clinical pharmacy experience while working as a pharmacy intern at both Meijer pharmacy and Marion Health Hospital.   Beyond her academic and professional endeavors, Lexi is deeply committed to giving back to the community. She serves as a board member for an organization called Guatemala Family Development where she contributed to initiatives aimed at improving healthcare access and promoting wellness in underserved communities. At the time this episode was recorded, Lexi was completing an advanced pharmacy practice experience with Dr. Becky Winslow, preceptor for Manchester University School of Pharmacy.  Dr. Mary Weissman is a clinical pharmacogenomics specialist and inGENEious RX Incorporated consultant. Since earning her Doctor of Pharmacy degree from Arnold and Marie Schwartz College of Pharmacy and completing a two-year pharmacogenomics fellowship in a clinical laboratory's medical affairs department, Dr. Weissman has applied her pharmacogenomics expertise in clinical diagnostic laboratories. At those laboratories, she has scientifically, and clinically supported pharmacogenomics stakeholders to increase clinical pharmacogenomics implementation into clinical settings. Holding titles such as clinical scientist, she has authored and developed medical content to educate healthcare providers and patients about pharmacogenomics and authored clinical decision support tools prescribers use to leverage pharmacogenomic insights in medication therapy management. Through educational trainings, white papers, presentations, and webinars, she has clarified pharmacogenomics' complexities and helped move pharmacogenomics toward a standard of care.  

Before founding inGENEious RX Incorporated, a boutique pharmacogenomics consulting firm, Dr. Winslow directed pharmacy business operations and clinical pharmacy programs in retail, hospital, long-term care, and public health pharmacies for Walmart Stores, Community Health Systems, Neil Medical Group, and the North Carolina Department of Health and Human Services. Since founding inGENEious RX over eleven years ago, Dr. Winslow has worked with numerous distinguished vendors in the pharmacogenomics industry including Translational Software, Admera Health, Genemarkers, National Association of Chain Drug Stores, Kentucky Teachers' Retirement System, GenXys, and Thermo Fisher Scientific.  A sought-after pharmacogenomics subject matter expert, Dr. Winslow, has authored PGx payer databases and billing and coding algorithms and served Mintz Law as the expert medical necessity reviewer of Medicare PGx claims. She is an authority in pharmacogenomics access and reimbursement and specializes in business strategy consulting for pharmacogenomics stakeholders.   Dr. Winslow is an Advanced Pharmacy Practice Experience preceptor for Manchester University School of Pharmacy PharmD/Masters in PGx students and a registered trainer for the University of Pittsburgh's Test2Learn (TM) Community PGx Certificate Program. Dr. Winslow is a member of the Clinical Pharmacogenetics Implementation Consortium, the NCPDP PGx Task Force, and the Get the Medications Right Institute.  In 2021, Welp Magazine recognized Dr. Winslow's podcast, the PGx for Pharmacists Podcast, as the world's ninth most listened-to genetics podcast. Her podcast shares the top 20 most listened-to genomics podcast list with genomics podcasts created by such notable podcasters as the National Cancer Institute and the American Heart Association. The Pharmacy Podcast Network recognized Dr. Winslow in 2021 as a Top 50 pharmacy influencer. Entities frequently recruit Dr. Winslow to present PGx topics. She has presented at conferences for the National Association of Boards of Pharmacy, the National Association of Specialty Pharmacy, the Inovalon Customer Congress, and the Association for Molecular Pathology and on the Labroots' and Precision Medicine Institute's platforms.  Dr. Winslow earned her Bachelor of Science in Biology and Doctor of Clinical Pharmacy degrees from Campbell University. Lexi Wensel is a 2024 Manchester University School of Pharmacy graduate where she earned her Doctorate in Pharmacy and Masters in Pharmacogenomics. When this episode was recorded in April 2024, Lexi was completing an advanced pharmacy practice experience with Dr. Becky Winslow, preceptor for Manchester University School of Pharmacy. While studying to become a pharmacist, Lexi gained practical clinical pharmacy experience while working as a pharmacy intern at both Meijer pharmacy and Marion Health Hospital.   Beyond her academic and professional endeavors, Lexi is deeply committed to giving back to the community. She serves as a board member for an organization called Guatemala Family Development where she contributed to initiatives aimed at improving healthcare access and promoting wellness in underserved communities. At the time this episode was recorded, Lexi was completing an advanced pharmacy practice experience with Dr. Becky Winslow, preceptor for Manchester University School of Pharmacy.  Dr. Mary Weissman is a clinical pharmacogenomics specialist and inGENEious RX Incorporated consultant. Since earning her Doctor of Pharmacy degree from Arnold and Marie Schwartz College of Pharmacy and completing a two-year pharmacogenomics fellowship in a clinical laboratory's medical affairs department, Dr. Weissman has applied her pharmacogenomics expertise in clinical diagnostic laboratories. At those laboratories, she has scientifically, and clinically supported pharmacogenomics stakeholders to increase clinical pharmacogenomics implementation into clinical settings. Holding titles such as clinical scientist, she has authored and developed medical content to educate healthcare providers and patients about pharmacogenomics and authored clinical decision support tools prescribers use to leverage pharmacogenomic insights in medication therapy management. Through educational trainings, white papers, presentations, and webinars, she has clarified pharmacogenomics' complexities and helped move pharmacogenomics toward a standard of care.  

Shaun Jensen, JB Consulting  Rafael Saenz, Chief of Staff at APhA Reed Kalna, PharmD Chairman of the Specialty Pharmacy Certification Board Russell Robbins MD, MBA & Diane Faraone, PharmD | PurpleLab Charles Collins, President at Healthcare Stakeholder Solutions Courtney Smith, PharmD Elsen Jacob, PharmD, MS Cencora Steven Garceau, Senior Director of Payer Strategy Andrew Babb, Biotech Remedies Shelia Arquette, Closing NASP

During this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, speaks with Amy Niles, the Chief Mission Officer of the PAN Foundation, about the impact of advocacy and education on enhancing access to care in the face of rising health care costs, the 2025 Medicare reforms and what NASP members need to know, as well as the many initiatives and tools the PAN Foundation employs to help patients who might otherwise walk away from the pharmacy counter.   

Perigon Pharmacy 360 Chris Antypas PharmD Harry Travis NASP 2024 Jeff Wandzura KEEP Labs Shawn Francis PharmD | Children's National Hospital Richard Brook President | Better Health Worldwide Eric Huckins LumiceraHealth

This Week in Pharmacy – November 9, 2024 Episode Title: Addressing Patient Needs and Advocacy with Jennifer Noonan, VP of Clinical Strategy and Patient Engagement Show Notes: In this insightful episode of This Week in Pharmacy, we welcome Jennifer Noonan, Vice President of Clinical Strategy and Patient Engagement at Accessia Health, to discuss the current and future landscape of patient care. Join us as we explore the unique needs of patients, particularly within specialty pharmacy, and uncover resources that can provide crucial support. Conversation Highlights: Current State of Patient Care Jennifer shares her perspective on the pressing needs of patients today and whether their financial, educational, and advocacy needs are being adequately met. We delve into the varying needs of patients with different disease states and explore the specific support required for those navigating complex healthcare journeys. Discussion points include: Financial Assistance – Understanding the essential financial support patients seek and how various programs step in to alleviate the burden. Patient Advocacy and Education – Highlighting the importance of patient education programs and recent efforts like the CMS webinar series to empower patients. Health Equity and SDOH – Addressing the gaps in social determinants of health and equity in care, and how they impact patient outcomes. Resources Available to Patients Jennifer discusses often-overlooked resources like Patient Assistance Programs (PAPs), especially Accessia Health's support beyond copay assistance. Listeners gain insight into: Financial Support Programs – Beyond the basics, Accessia Health provides comprehensive assistance tailored to specific patient needs. Educational Programs – How initiatives such as CMS webinars bridge knowledge gaps and empower patients to make informed choices. Filling Gaps in Health Equity – Steps being taken to close disparities and ensure all patients have access to equitable care. Future of Specialty Pharmacy and Patient Engagement Jennifer shares her outlook on the changes expected in the specialty pharmacy space over the next few years. Topics include: Rising Healthcare Costs and Legislation – How the Inflation Reduction Act (IRA) and upcoming CMS changes could reshape the landscape for patients. Cell and Gene Therapy Advances – The impact of groundbreaking treatments and the importance of ensuring patients have access to these innovations. Getting in Touch with Accessia Health Jennifer concludes with ways patients, caregivers, and healthcare providers can connect with Accessia Health to learn more about the resources and support available. Connect with Us: For more information about this episode and to reach out to Accessia Health, visit AccessiaHealth.org. Don't forget to subscribe to This Week in Pharmacy for the latest insights in healthcare and pharmacy. Join us as we uncover how healthcare professionals, patients, and advocates can come together to address today's challenges and build a more inclusive future for all.

Accessia Health 12 min Jennifer Noonan RN Jonathan Orguchack Stack NASP Juliana DeFrancis BlueSky Specialty Pharmacy Mei Tang, Pharm.D., MBA | Two Trees Consulting Michael Meader Altor Solutions Cold Packs Mike Baldzicki (sp) Nick Ruiz keycentrix Allison Arant Clearway Health

In this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, visits with Mary Oates, MD, US Medical Lead, Bone Franchise with Amgen, to discuss post menopausal osteoporosis and what clinical pharmacists can do to support patients.  

AcariaHealth (Sponsored) Aleata Postell, Senior Director | Walmart Specialty Orlando Vidal Jeffrey S. Baird | Brown & Fortunato Sarah Allen NavenHealth Ceceila Byers Surescripts Jon Hamrick, MBA, Cheryl Allen, BS Pharm, MBA, | Curatio Scientia

During this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, speaks with Stuart Kamin, SVP of Analytics and Innovation at Claritas Rx about the evolution of personalized medicine, the impact that it's had on market and patient access teams, and the use of data analytics and AI to support the patient experience.  

On #TWIRx "This Week in Pharmacy" --we start out with the WORLD WIDE Celebration of Pharmacists, World Pharmacist Day 2024, thank you to all the 4-Million Pharmacists on planet Earth. On September 25, 2024, the global community came together to celebrate World Pharmacists Day, shining a spotlight on the invaluable role pharmacists play in safeguarding public health. (Shout out to Katrina Azer & Anisha Patel)  HARMACY Film -- huge announcement from Dr. Anaïs Webster- Mennuti, Dr. Kristin Speer, and Marie Wilda! Go to HarmacyFilm.com  Thank you Josh Kent from Cannabis Pharmacy, forwarding education, programs to support independent pharmacy businesses, and delivering highest quality products, check them out CannabisPharmacy.com -- and the Education leaders from the Answer Page with Dr. Stephen Corn, M.D. and Dr. Meredith Fisher-Corn, M.D, they joined the Pharmacy Podcast Network for reliable education for healthcare providers.  Thank you Sykes & Company for your services for Pharmacy Owners and accounting management to 'Master the Margins' of your businesses. The Road-Trip Guy is back with another 'Pharmacy CrossRoads' host Bruce Kneeland. This episode is about growing your compounding pharmacy business. We're proud of the Pediatirc Pharmacist leaders, 'Perfecting Peds' and their latest podcast episode on CFTR (Cystic fibrosis), take a listen!  Cardinal Health is focused on 'Why Independent Pharmacy' with Barry Christensen on 'Counter Talk' podcast --this is a great podcast about why it's time to build your community pharmacy, Cardinal Health is ready help build your pharmacy in 2025.  What's QHIN and how is Surescripts leading the way in 'qualified health information networks' will impact healthcare. We had a wonderful discussion lead by Dr. Simi Burn, PharmD, with special guests Ashton S. Maaraba, J.D. with IPC and Ritesh Patel with FINN Partners for being part of this discussion about #DigitalHealth inside Community Pharmacy today.  The 50 Most Influential People in Pharmacy Awards are getting ready to launch! Who do you think is an influential leader in Pharmacy Care? We're so proud to be launching the 4th #Pharmacy50 Awards in October 2024. Shout Out to the # 1 for 2023, Dr. Nadia Ahmad, PharmD --with Walgreens. Thank you Nadia for a special recognition of my work in pharmacy, thank you.  First featured guest today on TWIRx is a specialty pharmacy 'Slayer of Healthcare Barriers' Jennifer Noonan, MSN, RN, with Accessia Health, helping patients find funding for their medications when all hope seems lost, this company fights for the patient's pharmacy care.  Perigon Pharmacy 360, President Dr. Chris Antypas, PharmD., will be featured at the NASP Annual Event on the PPN's PRess coverage of the conference and he's here with us on TWIRx. Chris shares about how his specialty pharmacy is combining technology, pharmacy care plans, specialty & rare disease specialty pharmacists to innovate pharmacy care.  Shaun Jensen with JB Consulting will be at NASP ready to talk about helping Specialty Pharmacies build custom systems, software programs, and APIs to make your workflow, your mobile apps, and how to best leverage A.I. to help dial into your specialty pharmacy operations on another level. Shaun and his team build powerful programs specific to your operations needs. We can't wait to talk with Shaun in Nashville.  Thank you Shelia Arquette, CEO of the NASP for your unwavering support of Specialty Pharmacy excellence. Your impact on specialty care has been incredible. See everyone in Nashville. 

During this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, speaks with Gary Conte, Vice President of Business Development with HealthPlan Data Solutions (HDS), about innovations in prescription analytics that allow for daily script-level insights into the performance and trends of specialty pharmacy business.

This episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, speaks with Kathryn Eshelman, MD, MPH, Vice President of Clinical Informatics at Inovalon, about the evolving role of pharmacists and how leveraging technology can enhance patient outcomes while reducing administrative burdens.

During this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, speaks with Linda Clark and Brad Gallagher, Co-leaders of the Health Care Controversies Team at Barclay Damon, about the recent Federal Trade Commission (FTC) interim report on Pharmacy Benefit Managers (PBMs), challenges specialty pharmacies experience when impacted by anti-competitive practices, and a future for specialty pharmacy that broadens the profession and continues to facilitate excellent patient care.

Sheila Arquette, President & CEO of NASP, speaks with Tim McLeroy, Executive Director of Marketing & Patient Services at Noble International, and Terry Spalding, Senior User experience/Human factors Researcher at Noble International and a Registered Nurse